Cerenis Therapeutics pushes cholesterol drug development and job growth in A2

Cerenis Therapeutics is turning a bunch of Pfizer refugees into drug research company on both side of the Atlantic Ocean.

Getting your Trinity Audio player ready...

Many of the Pfizer’s former Ann Arbor employees are staying put, even though the drugmaker’s campus is closing and the jobs are leaving. More than a few Pfizer refugees have found safe jobs throughout the area and Cerenis Therapeutics is one of the places offering a safe harbor.

“When Pfizer closed the facility in Ann Arbor several people decided to join us,” says Jean-Louis Dasseux, co-founder of Cerenis Therapeutics.

Read the rest of the story here. 

Author

Our Partners

City of Oak Park

Don't miss out!

Everything Detroit, in your inbox every week.

Close the CTA

Already a subscriber? Enter your email to hide this popup in the future.